Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.30 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26319258 | 0.86 | FDPS (0.31) | FDPS | |
| SCHEMBL14093062 | 0.76 | FDPS (0.37) | FDPSTP53CA1CA2EPHX1 | |
| SCHEMBL18539394 | 0.75 | TSHR (0.30) | — | |
| Sulfuric Acid SCHEMBL28902407 | 0.73 | TP53 (0.41) | FDPSTP53CA1CA2EPHX1 | |
| Sulfuric Acid SCHEMBL6200765 | 0.73 | TP53 (0.41) | FDPSTP53CA1CA2EPHX1 | |
| Sulfuric Acid SCHEMBL5460746 | 0.73 | FDPS (0.43) | FDPSTP53GGPS1 | |
| SCHEMBL8522664 | 0.71 | FDPS (0.37) | FDPSTP53CA1CA2GGPS1 | |
| SCHEMBL14445395 | 0.71 | GGPS1 (0.42) | FDPSCA1CA2GGPS1 | |
| SCHEMBL7563586 | 0.71 | FDPS (0.44) | FDPSTP53CA1CA2GGPS1 | |
| SCHEMBL22115552 | 0.71 | FDPS (0.44) | FDPSTP53CA1CA2GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11687000-B2 | Sulfonium compound, chemically amplified resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11687000-B2 | Sulfonium compound, chemically amplified resist composition, and patterning process | ETV6, PKD1, PKD2 | FDPS 4110/4885TP53 2849/4885CA1 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.